Current Pharmaceutical Design

Author(s): Peter E. Czabotar and Guillaume Lessene

DOI: 10.2174/138161210793292429

DownloadDownload PDF Flyer Cite As
Bcl-2 Family Proteins as Therapeutic Targets

Page: [3132 - 3148] Pages: 17

  • * (Excluding Mailing and Handling)

Abstract

The mitochondrion provides the stage for the interplay of molecular interactions that regulate apoptosis via the intrinsic pathway. The release of apoptogenic factors from this compartment constitutes a critical juncture in this apoptotic pathway. Regulation of the integrity of the outer mitochondrial membrane (OMM) is the task of the Bcl-2 family of proteins. A network of interactions between the various subgroups of the family decides the apoptotic fate of a cell and, as such, an imbalance within this network can lead to a variety of disease states. In particular, over-expression of pro-survival Bcl-2 family proteins is a hallmark of many cancers. Here we discuss recent advances in targeting the Bcl-2 family with both peptides and small molecules.

Keywords: Apoptosis, Bcl-2